Latest news
Annexon announces tanruprubart data from FORWARD study - TipRanksTipRanks · Thu, 06 Aug 2026 22:02:22 GMTGoldman Sachs reiterates Neutral on Annexon stock after GBS data - Investing.comInvesting.com · Thu, 06 Aug 2026 21:07:00 GMTAnnexon says tanruprubart shows rapid strength gains in first 10 GBS FORWARD study patients - BitgetBitget · Thu, 06 Aug 2026 19:02:10 GMTAnnexon Announces Positive Clinical Outcomes from GBS FORWARD Study on Tanruprubart - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 17:44:27 GMTAnnexon, Inc. Reports Early Clinical Responses in First U.S. and European Patient Cohort of GBS FORWARD Study with Tanruprubart - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 15:47:18 GMTAnnexon Highlights Promising Early FORWARD GBS Study Results - TipRanksTipRanks · Thu, 06 Aug 2026 13:13:24 GMTAnnexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:00:00 GMT2-Yr Benchmark Govt Yields - Germany vs Other Nations - BitgetBitget · Wed, 05 Aug 2026 13:15:43 GMT